CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Sales revenues:
Total sales revenues	$ 84,622	$ 82,726	$ 170,855	$ 160,597
Costs of sales:
Total costs of sales	44,133	42,053	88,310	78,734
Gross profit	40,489	40,673	82,545	81,863
Operating expenses:
Product development	10,595	8,107	20,434	16,169
Sales and marketing	8,132	8,226	15,089	15,269
General and administrative	19,654	14,994	34,604	28,421
Amortization of acquisition-related intangibles	4,014	4,758	8,029	8,430
Total operating expenses	42,395	36,085	78,156	68,289
Operating income (loss)	(1,906)	4,588	4,389	13,574
Other income (expense):
Other income	78	278	346	435
Gain on contingent consideration	0	330	0	1,580
Loss on extinguishment of debt	0	(125)	0	(125)
Interest expense	(2,664)	(1,232)	(5,334)	(2,149)
Total other income (expense)	(2,586)	(749)	(4,988)	(259)
Income (loss) before taxes	(4,492)	3,839	(599)	13,315
Provision (benefit) for income taxes	(1,655)	763	(846)	2,126
Net income (loss)	$ (2,837)	$ 3,076	$ 247	$ 11,189
Net income per common share-basic (in dollars per share)	$ (0.20)	$ 0.21	$ 0.02	$ 0.76
Net income per common share-diluted (in dollars per share)	$ (0.20)	$ 0.21	$ 0.02	$ 0.76
Weighted average shares outstanding used in per common share computations:
Basic (in shares)	14,200	14,469	14,168	14,425
Diluted (in shares)	14,200	14,469	14,168	14,425
RCM
Sales revenues:
Total sales revenues	$ 47,760	$ 46,814	$ 96,391	$ 87,325
Costs of sales:
Total costs of sales	27,119	25,382	54,302	45,780
EHR
Sales revenues:
Total sales revenues	34,967	34,143	70,158	68,905
Costs of sales:
Total costs of sales	15,891	15,721	32,239	31,061
Patient Engagement
Sales revenues:
Total sales revenues	1,895	1,769	4,306	4,367
Costs of sales:
Total costs of sales	$ 1,123	$ 950	$ 1,769	$ 1,893